Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein

John C Cooper1, Jared N Boustead, Chao-Lan Yu

  • 1Department of Molecular Physiology and Biophysics, Room 813B Light Hall, Vanderbilt University School of Medicine, Nashville, TN 37232-0615, USA.

Cellular Signalling
|August 30, 2005
PubMed

Insights

Defective expression of Cytokine-inducible SH2-containing protein (CIS) in cancer cells is linked to altered STAT5b phosphorylation. This finding suggests new mechanisms beyond DNA hypermethylation impacting gene expression in tumors.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Signal Transduction

Background:

  • Cytokine-inducible SH2-containing protein (CIS) is a key negative regulator in cytokine signaling pathways.
  • Other suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation in cancer, leading to uncontrolled STAT activation.
  • The regulation of CIS expression in tumor cells remains largely uncharacterized.

Purpose of the Study:

  • To investigate the expression status of CIS in T lymphoma cells with elevated STAT5 activity.
  • To explore the mechanisms underlying potential defects in CIS gene expression in cancer.
  • To identify novel post-translational modifications of STAT5b influencing CIS gene regulation.

Main Methods:

  • Analysis of CIS expression in LSTRA T lymphoma cells and BaF3 cells.
  • Assessment of STAT5 binding to the CIS promoter using in vivo assays.
  • SDS-polyacrylamide gel electrophoresis (SDS-PAGE) for STAT5b modification analysis.
  • In vitro phosphatase assays and phosphoamino acid analysis.

Main Results:

  • CIS expression was absent in LSTRA T lymphoma cells with high STAT5 activity.
  • CIS induction in response to IL-3 in BaF3 cells correlated with specific STAT5b post-translational modifications.
  • A distinct, slowly migrating form of STAT5b, associated with nuclear accumulation and promoter binding, was identified.
  • Phosphorylation on non-canonical sites of STAT5b was implicated in this mobility shift.

Conclusions:

  • Defective CIS expression in cancer cells may involve mechanisms other than DNA hypermethylation.
  • Specific STAT5b post-translational modifications, potentially involving non-canonical phosphorylation, are critical for CIS gene induction.
  • This study reveals a novel link between aberrant STAT5b phosphorylation and impaired SOCS gene expression in the context of cancer.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...